0.45 USD
↗ 0.03 (7.88%)AT CLOSE (03:59 PM EST)
Lucid Diagnostics Inc. Common Stock
LUCDNASDAQ • USD
0.46
↗ 0.01 (1.31%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
0.46
↗ 0.01 (1.31%)
Market: CLOSED
Lucid Diagnostics Inc. Common Stock (LUCD) trades at $0.45 per share. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Furthermore, LUCD is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Nov 13, 2026.
Open?$0.44
High?$0.49
Low?$0.42
Prev. Close?$0.42
Volume?3.5M
Avg. Volume?9.4M
VWAP?$0.46
Rel. Volume?0.37x
Bid / Ask
Bid?$0.45 × 5.5K
Ask?$0.46 × 700
Spread?$0.01
Midpoint?$0.45
Valuation & Ratios
Market Cap?85.9M
Shares Out?203.2M
Float?156.5M
Float %?77.1%
P/E Ratio?N/A
P/B Ratio?7.86
EPS?-$0.34
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Themes
Employees
82
Market Cap
79.5M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
2021-10-14
Address
360 MADISON AVENUE
NEW YORK, NY 10017
Phone: 212 949 4319
NEW YORK, NY 10017
Phone: 212 949 4319
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?0
Momentum?27
Short Sent.?68
Piotroski F-Score?3/9Weak
Altman Z-Score?-13.27Distress
Confidence?51%Low
Short InterestElevated
Short % of Float?9.58%Elevated
Short Interest?15.0M
Days to Cover?1.0
Free Float156.5M
Avg Daily Volume21.9M
Settlement Date2026-10-30
Financial Health
Current Ratio?1.33Adequate
Quick Ratio?1.31Adequate
Cash Ratio?1.21Strong
Debt/Equity?2.15High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?7.86FAIR▾
Peers100
S&P24
P/S?15.78HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.5CHEAP▾
S&P97
EV/Sales?13.96HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-594.9%WEAK▾
S&P3
ROA?-166.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-47184000
Enterprise Value?$76.0M
Fundamentals ratios updated end of day